Back to clinical trials
RecruitingObservational
Understanding Chronic Lymphocytic Leukemia
NCT ID: NCT04028531Sponsor: Dana-Farber Cancer InstituteLast updated: 2026-04-24
Summary
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
Detailed description
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.
Arms & interventions
Outcome measures
Primary
Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia
Exploratory science to better understand Chronic Lymphocytic Leukemia
Time frame: 20 years
Eligibility criteria
Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria:
* New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
* Any low grade lymphoproliferative disorder
* Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
Exclusion Criteria:
\-
Study locations (1)
Dana Farber Cancer Institute
Boston, Massachusetts, 02115
Jennifer Brown, MD, PhD · Principal Investigator